National Research Corp (NASDAQ:NRC) — Market Cap & Net Worth
Market Cap & Net Worth: National Research Corp (NRC)
National Research Corp (NASDAQ:NRC) has a market capitalization of $462.71 Million ($462.71 Million) as of September 16, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #12701 globally and #3149 in its home market, demonstrating a 2.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying National Research Corp's stock price $21.96 by its total outstanding shares 22139315 (22.14 Million). Also see NRC total asset value for a full breakdown of the balance sheet.
National Research Corp Market Cap History: 2015 to 2026
National Research Corp's market capitalization history from 2015 to 2026. Data shows growth from $301.58 Million to $486.18 Million (6.17% CAGR). Also see how efficiently does National Research Corp generate cash for how efficiently the company converts equity into cash flow.
Index Memberships
National Research Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.02% | #346 of 976 |
|
NASDAQ Composite
IXIC
|
$41.74 Trillion | 0.00% | #1263 of 3165 |
Weight: National Research Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
National Research Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how National Research Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check NRC share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
3.02x
National Research Corp's market cap is 3.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
35.82x
National Research Corp's market cap is 35.82 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $365.16 Million | $109.38 Million | $20.52 Million | 3.34x | 17.80x |
| 2017 | $727.04 Million | $117.56 Million | $22.94 Million | 6.18x | 31.69x |
| 2018 | $766.10 Million | $119.69 Million | $30.05 Million | 6.40x | 25.50x |
| 2019 | $1.34 Billion | $127.98 Million | $32.41 Million | 10.50x | 41.47x |
| 2020 | $875.47 Million | $133.28 Million | $37.26 Million | 6.57x | 23.50x |
| 2021 | $859.23 Million | $147.95 Million | $37.47 Million | 5.81x | 22.93x |
| 2022 | $788.18 Million | $151.57 Million | $31.80 Million | 5.20x | 24.79x |
| 2023 | $863.95 Million | $148.58 Million | $30.97 Million | 5.81x | 27.90x |
| 2024 | $390.54 Million | $143.06 Million | $24.78 Million | 2.73x | 15.76x |
| 2025 | $415.55 Million | $137.39 Million | $11.60 Million | 3.02x | 35.82x |
Competitor Companies of NRC by Market Capitalization
Companies near National Research Corp in the global market cap rankings as of September 16, 2026. Review NRC tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to National Research Corp by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #738 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1902 globally with a market cap of $12.23 Billion USD ( AU$17.28 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2076 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2133 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #738 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $266.62 |
| #1902 | Pro Medicus Ltd | AU:PME | $12.23 Billion | AU$165.45 |
| #2076 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $68.85 |
| #2133 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $58.84 |
National Research Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, National Research Corp's market cap moved from $301.58 Million to $ 486.18 Million, with a yearly change of 6.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $486.18 Million | +17.00% |
| 2025 | $415.55 Million | +6.41% |
| 2024 | $390.54 Million | -54.80% |
| 2023 | $863.95 Million | +9.61% |
| 2022 | $788.18 Million | -8.27% |
| 2021 | $859.23 Million | -1.86% |
| 2020 | $875.47 Million | -34.85% |
| 2019 | $1.34 Billion | +75.41% |
| 2018 | $766.10 Million | +5.37% |
| 2017 | $727.04 Million | +99.10% |
| 2016 | $365.16 Million | +21.08% |
| 2015 | $301.58 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of National Research Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $462.71 Million USD |
| MoneyControl | $462.71 Million USD |
| MarketWatch | $462.71 Million USD |
| marketcap.company | $462.71 Million USD |
| Reuters | $462.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About National Research Corp
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, an… Read more